We are live on ! Find out more
NDRA icon

ENDRA Life Sciences
NDRA

8 hedge funds and large institutions have $268K invested in ENDRA Life Sciences in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 8 → 8 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

30% less capital invested

Capital invested by funds: $385K → $268K (-$117K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$61.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$59.1K
3
HF
HRT Financial
New York
+$16.9K
4
Renaissance Technologies
Renaissance Technologies
New York
+$16.9K
5
TSS
Two Sigma Securities
New York
+$16.9K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$42.2K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$39.4K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$35.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$28.7K
5
JP Morgan Chase
JP Morgan Chase
New York
-$16.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$82.4K +$61.9K +22 +200%
Citadel Advisors
2
Citadel Advisors
Florida
$52.1K +$59.1K +21 New
NA
3
NewEdge Advisors
Louisiana
$45.2K -$2.82K -1 -5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$37.2K -$39.4K -14 -48%
TSS
5
Two Sigma Securities
New York
$15.9K +$16.9K +6 New
Renaissance Technologies
6
Renaissance Technologies
New York
$15K +$16.9K +6 New
HF
7
HRT Financial
New York
$14K +$16.9K +6 New
TRCT
8
Tower Research Capital (TRC)
New York
$3.49K +$2.82K +1 New
Morgan Stanley
9
Morgan Stanley
New York
$1.09K -$42.2K -15 Closed
WAM
10
Worth Asset Management
Texas
$938 – – –
BlackRock
11
BlackRock
New York
$144 – – –
Wells Fargo
12
Wells Fargo
California
$70 – – –
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
– -$35.3K -9 Closed
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
– -$28.7K -7 Closed
JP Morgan Chase
15
JP Morgan Chase
New York
– -$16.2K -4 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
– -$10.3K -3 Closed
CWM
17
Cranbrook Wealth Management
Michigan
– -$623 – –
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$2K – –

NDRA Hedge Fund Activity: Q2 2023 in Review

8 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2023, worth a combined $268K — down 30% from $385K a quarter earlier.

Fund positioning in NDRA was balanced in Q2 2023: 5 funds opened new positions, 5 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $61.9K. The largest seller was Morgan Stanley, exiting entirely with an estimated $42.2K sold.

  • 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $268K of ENDRA Life Sciences stock for Q2 2023, down 30% quarter-over-quarter.
  • 5 funds opened new ENDRA Life Sciences positions in Q2 2023 and 5 closed out, a net change of 0 holders.
  • The largest ENDRA Life Sciences buyer in Q2 2023 was Geode Capital Management, an estimated $61.9K added.
  • The largest ENDRA Life Sciences seller in Q2 2023 was Morgan Stanley, an estimated $42.2K sold.

Based on aggregated 13F filings for Q2 2023.